Data-driven health innovation may lead to develop targeted treatments using health data. We consider privacy-sensitive patients who may decide to share personal health data if compensated. Each patient does not internalize the impact of sharing data on drug innovation. We show that investment incentives in targeted treatments are too weak as long as such innovation has a public good nature so that patients can free ride on sharing health data. Then, privacy protection measures reducing data sharing risks can promote pharmaceutical R&D and social welfare
Data-Driven Health Innovation and Privacy Regulation / Conti, C.; D'Annunzio, A.; Reverberi, P.. - In: THE B.E. JOURNAL OF ECONOMIC ANALYSIS & POLICY. - ISSN 1935-1682. - 24:1(2024), pp. 329-338. [10.1515/bejeap-2023-0020]
Data-Driven Health Innovation and Privacy Regulation
Conti C.;Reverberi P.
2024
Abstract
Data-driven health innovation may lead to develop targeted treatments using health data. We consider privacy-sensitive patients who may decide to share personal health data if compensated. Each patient does not internalize the impact of sharing data on drug innovation. We show that investment incentives in targeted treatments are too weak as long as such innovation has a public good nature so that patients can free ride on sharing health data. Then, privacy protection measures reducing data sharing risks can promote pharmaceutical R&D and social welfare| File | Dimensione | Formato | |
|---|---|---|---|
|
Conti_Data-Driven_2024.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
2.62 MB
Formato
Adobe PDF
|
2.62 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
